The first authoritative collection of recent breakthroughs in Parkinson's disease (PD) research, this reference spans key findings on the mechanisms of neurodegeneration and the role of specific genes that may lead to improved therapies for PD. This guide will review the major aspects of the disease including motoric and pathologic features, and autonomic dysfunction, sleep disorders, and neuropsychiatric manifestations, as well as provide an in-depth review of genetic considerations. With contributions by recognized experts on the topic, this source will address the pathogenesis, experimental…mehr
The first authoritative collection of recent breakthroughs in Parkinson's disease (PD) research, this reference spans key findings on the mechanisms of neurodegeneration and the role of specific genes that may lead to improved therapies for PD. This guide will review the major aspects of the disease including motoric and pathologic features, and autonomic dysfunction, sleep disorders, and neuropsychiatric manifestations, as well as provide an in-depth review of genetic considerations. With contributions by recognized experts on the topic, this source will address the pathogenesis, experimental models, future therapeutic opportunities, and research trends affecting the field.
OVERVIEW. Neuropathology and Staging of Parkinson's Disease. Genetics of Parkinson's Disease. Epidemiology of Parkinson's Disease. Treatment of Parkinson's Disease. GENETICS. Genetics of Alpha-Synuclein. Clinical and Genetic Features of PARKIN-Related Parkinson's Disease. DJ-1 in Parkinson's Disease. PINK1 Parkinsonism. LRRK2. Genetics of Tau in Parkinsonism. Genetic Risk Factors for PD. PATHOGENESIS. Alpha-Synuclein and Parkinson's Disease. Tau in Parkinson's Disease. The Role of PARKIN in Parkinson's Disease. Mitochondrial Complex I Deficiency in Parkinson's Disease: A Mechanism for Oxidant-Based Pathogenesis. The Ubiquitin-Proteasome System in Parkinson's Disease. ANIMAL MODELS. Transgenic Models of Alpha-Synucleinopathy. Mouse Models of Recessive Parkinsonism. Drosophila Models of Parkinson's Disease. C. Elegans Models of Parkinson's Disease. The MPTP Model of Parkinson's Disease. Rotenone Model. Drug Trials in Animal Models of PD
OVERVIEW. Neuropathology and Staging of Parkinson's Disease. Genetics of Parkinson's Disease. Epidemiology of Parkinson's Disease. Treatment of Parkinson's Disease. GENETICS. Genetics of Alpha-Synuclein. Clinical and Genetic Features of PARKIN-Related Parkinson's Disease. DJ-1 in Parkinson's Disease. PINK1 Parkinsonism. LRRK2. Genetics of Tau in Parkinsonism. Genetic Risk Factors for PD. PATHOGENESIS. Alpha-Synuclein and Parkinson's Disease. Tau in Parkinson's Disease. The Role of PARKIN in Parkinson's Disease. Mitochondrial Complex I Deficiency in Parkinson's Disease: A Mechanism for Oxidant-Based Pathogenesis. The Ubiquitin-Proteasome System in Parkinson's Disease. ANIMAL MODELS. Transgenic Models of Alpha-Synucleinopathy. Mouse Models of Recessive Parkinsonism. Drosophila Models of Parkinson's Disease. C. Elegans Models of Parkinson's Disease. The MPTP Model of Parkinson's Disease. Rotenone Model. Drug Trials in Animal Models of PD
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309